As such, hyperinsulinemia in obesity and diabetes results in the development of steatosis through increasing hepatic lipogenesis; subsequently, the accumulation of hepatic lipid species, e.g., diacylglycerol (DAG) and ceramide, leads to the impairment of insulin signaling [195,196,197]. The gene discussed is INS; the disease is Hyperinsulinemia.